CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- S-3 Offering Registration Statement
- 144 Insider Sale of Securities
- 4 Planned sale Principal Accounting Officer sold 3,367 shares at $2.08 ($7,012)
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 8,071 shares at $2.12 ($17,138)
- 4 Open-market sale Chief Executive Officer sold 81,864 shares at $2.12 ($173,822)
- 4 Open-market sale CFO & Chief Business Officer sold 29,649 shares at $2.12 ($62,954)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Principal Accounting Officer sold 4,079 shares at $2.50 ($10,198)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
Page 4 of 32 · 631 filings